Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness - An Exploratory Study

Journal of Pain and Symptom Management

Volumn 51, Issue 2, 2016, Pages 247-254

  Ferreira, Diana H ^a   Silva, José P ^a   Quinn, Stephen ^b   Abernethy, Amy P ^c,d   Johnson, Miriam J ^e   Oxberry, Stephen G ^f   Currow, David C ^c  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b FLINDERS UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF HULL   (United Kingdom)

^f Kirkwood Hospice   (United Kingdom)

Author keywords

breathlessness; COPD; morphine; palliative care; Patient preference; randomized controlled trial

Indexed keywords

MORPHINE; PLACEBO; NARCOTIC ANALGESIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC REFRACTORY BREATHLESSNESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DYSPNEA; EXPLORATORY RESEARCH; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION; AGE; COMPARATIVE STUDY; COMPLICATION; FEMALE; MULTIVARIATE ANALYSIS; NAUSEA; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PATIENT PREFERENCE; PROCEDURES; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANALGESICS, OPIOID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MORPHINE; MULTIVARIATE ANALYSIS; NAUSEA; PALLIATIVE CARE; PATIENT PREFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; TREATMENT OUTCOME;

EID: 84955676774     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2015.10.005     Document Type: Article

References (33)

1. K. Moens, I.J. Higginson, and R. Harding Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review J Pain Symptom Manage 48 2014 660 677
2. A.P. Abernethy, and J.L. Wheeler Total dyspnoea Curr Opin Support Palliat Care 2 2008 110 113
3. A.L. Jennings, A.N. Davies, J.P.T. Higgins, J.S.R. Gibbs, and K.E. Broadley A systematic review of the use of opioids in the management of dyspnoea Thorax 57 2002 939 944
4. S.G. Oxberry, D.J. Torgerson, J.M. Bland, and et al. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial Eur J Heart Fail 13 2011 1006 1012
5. A.P. Abernethy, D.C. Currow, P. Frith, and et al. Randomized, double-blind, placebo controlled cross-over, trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 528
6. M.J. Johnson, T.A. McDonagh, A. Harkness, S.E. McKay, and H.J. Dargie Morphine for the relief of breathlessness in patients with chronic heart failure - a pilot study Eur J Heart Fail 4 2002 753 756
7. D.C. Currow, C. McDonald, S. Oaten, and et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study J Pain Symptom Manage 42 2011 388 399
8. M.P. Ekström, A. Bornefalk-Hermansson, A.P. Abernethy, and D.C. Currow Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study BMJ 348 2014 g445
9. M.J. Johnson, J.M. Bland, S.G. Oxberry, A.P. Abernethy, and D.C. Currow Opioids for chronic refractory breathlessness: patient predictors of beneficial response Eur Respir J 42 2013 758 766
10. M.J. Johnson, J.M. Bland, S.G. Oxberry, A.P. Abernethy, and D.C. Currow Clinically important differences in the intensity of chronic refractory breathlessness J Pain Symptom Manage 46 2013 957 963
11. J. Powers, and S.J. Bennett Measurement of dyspnea in patients treated with mechanical ventilation Am J Crit Care 8 1999 254 261
12. A.G. Gift, and G. Narsavage Validity of the numeric rating scale as a measure of dyspnea Am J Crit Care 7 1998 200 204
13. M.J. Johnson, J.M. Bland, P.M. Davidson, and et al. The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status Scale J Pain Symptom Manage 47 2014 652 658
14. C. Ma, S. Bandukwala, D. Burman, and et al. Interconversion of three measures of performance status: an empirical analysis Eur J Cancer 46 2010 3175 3183
15. T.P. Chua, D. Harrington, P. Ponikowski, and et al. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure J Am Coll Cardiol 29 1997 147 152
16. M. Krajnik, E. Jassem, and P. Sobanski Opioid receptor bronchial tree: current science Curr Opin Support Palliat Care 8 2014 191 199
17. D.A. Mahler, A.H. Gifford, L.A. Waterman, and et al. Effect of increased blood levels of β-endorphin on perception of breathlessness Chest 143 2013 1378 1385
18. R.B. Banzett, C.R. O'Donnell, T.E. Guilfoyle, and et al. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research Eur Respir J 4 2015 1681 1691
19. S.G. Oxberry, J.M. Bland, A.L. Clark, J.G. Cleland, and M.J. Johnson Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough J Palliat Med 16 2013 250 255
20. M. Piepoli, A. Radaelli, P. Ponikowski, and et al. Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients Clin Sci (Lond) 91 Supp 1 1996 87 88
21. L. Wilson, A. Loucks, C. Bui, and et al. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices J Neurol Sci 344 2014 80 87
22. A.C. Mühlbacher, and S. Bethge Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer Eur J Health Econ 16 2015 657 670
23. N.J. Williams, G. Jean-Louis, A. Pandey, and et al. Excessive daytime sleepiness and adherence to antihypertensive medications among Blacks: analysis of the counseling African Americans to control hypertension (CAATCH) trial Patient Prefer Adherence 8 2014 283 287
24. D. Larrey, M.P. Ripault, and G.P. Pageaux Patient adherence issues in the treatment of hepatitis C Patient Prefer Adherence 8 2014 763 773
25. S. Sloot, J. Boland, J.A. Snowden, and et al. Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study Support Care Cancer 23 2015 671 678
26. R.S. Gregorian, A. Gasik, W.J. Kwong, S. Voeller, and S. Kavanagh Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians J Pain 11 2010 1095 1108
27. J.K. Schmier, C.S. Palmer, E.M. Flood, and G. Gourlay Utility assessments of opioid treatment for chronic pain Pain Med 3 2002 218 230
28. D.J. Karras, M.E. Sammon, C.A. Terregino, and et al. Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327 334
29. D.S. Ander, I.P. Aisiku, J.J. Ratcliff, K.H. Todd, and K. Gotsch Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 10 2004 188 191
30. A.L. Ries Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale COPD 2 2005 105 110
31. R.T. Martins, D. Currow, A.P. Abernethy, and et al. Effects of low dose morphine on perceived sleep quality in patients with refractory breathlessness: a hypothesis generating study Respirology 2015 in press
32. G.J. Knafl, and B. Riegel What puts heart failure patients at risk for poor medication adherence? Patient Prefer Adherence 8 2014 1007 1018
33. D.C. Currow, A.P. Abernethy, and M.J. Johnson Activity as a measure of symptom control J Pain Symptom Manage 44 2012 e1 e2